Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 11Other hematologic neoplasm 6Thoracic 1Sarcoma 1Plasma cell 1Other solid neoplasm 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Melanoma 3Stomach Neoplasms 1Sarcoma, Synovial 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Multiple Myeloma 1Mesothelioma 1Lymphoma 1Lung Neoplasms 1Leukemia, Myeloid 1Glioma 1Esophageal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Burkitt Lymphoma 1

Interventions

Peripheral Blood Stem Cell Transplantation 39Cyclophosphamide 33fludarabine phosphate 32Whole-Body Irradiation 24Mycophenolic Acid 24Cyclosporine 24Busulfan 22Tacrolimus 19Antilymphocyte Serum 19Methotrexate 16Filgrastim 16Etoposide 15Methylprednisolone 12Melphalan 12Flow Cytometry 11Radiotherapy 10Psychiatric Rehabilitation 10Therapeutics 9Polymerase Chain Reaction 8Rituximab 7Sirolimus 6sargramostim 5Vorinostat 5Thiotepa 5Gemcitabine 5Cord Blood Stem Cell Transplantation 5Carboplatin 5tanespimycin 4Pharmacogenomic Testing 4Ondansetron 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Burkitt Lymphoma × Immunotherapy, Adoptive × Dermatologic × Clear all
NCT03638206 2019-12-11

Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies

Shenzhen BinDeBio Ltd.

Phase 1/2 Unknown
73 enrolled
CNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidOther hematologic neoplasmOther solid neoplasmPlasma cellSarcomaThoracic

Burkitt Lymphoma, Carcinoma, Renal Cell, Esophageal Neoplasms, Glioma, Carcinoma, Hepatocellular, Leukemia, Myeloid, Lung Neoplasms, Lymphoma, Melanoma, Mesothelioma, Multiple Myeloma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Sarcoma, Synovial, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡